Haemostatic problems in acute leukaemia
- PMID: 2076471
- DOI: 10.1016/0268-960x(90)90004-c
Haemostatic problems in acute leukaemia
Abstract
Disseminated intravascular coagulation (DIC) is a frequent complication of acute leukaemia, in particular acute promyelocytic leukaemia. Although procoagulant substances released from leukaemic blast cells may induce DIC by activating conventional coagulation pathways, there is increasing evidence to suggest that direct activation of fibrinogen by proteases released from blast cells may be the predominant mechanism by which DIC is initiated. Primary fibrinolysis has also been proposed as the cause of the haemorrhagic diathesis in some cases of acute leukaemia. Although plasminogen activators have been demonstrated in leukaemic blast cells supporting this view, cases of primary fibrinolysis would appear to be rare. A bleeding tendency attributed to primary fibrinolysis may more often be the result of an exaggerated fibrinolytic response secondary to DIC. The main strategies of treatment for leukaemia associated DIC are rapid initiation of chemotherapy and vigorous blood product support until the DIC resolves once the blast cells have been eradicated. The role of heparin in the management of leukaemia associated DIC remains controversial. There is recent evidence to suggest that heparin therapy does reduce the incidence of haemorrhagic death although it has been recommended that relatively low intravenous doses should be administered initially to reduce the risk of heparin induced haemorrhage.
Similar articles
-
Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia.Best Pract Res Clin Haematol. 2003 Sep;16(3):463-82. doi: 10.1016/s1521-6926(03)00059-8. Best Pract Res Clin Haematol. 2003. PMID: 12935963 Review.
-
Haemostatic problems in acute promyelocytic leukaemia.Blood Rev. 2006 Nov;20(6):289-97. doi: 10.1016/j.blre.2006.04.001. Epub 2006 Jun 6. Blood Rev. 2006. PMID: 16757074 Review.
-
[Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].Sangre (Barc). 1993 Dec;38(6):449-53. Sangre (Barc). 1993. PMID: 8171380 Spanish.
-
[Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Apr;22(2):315-22. doi: 10.7534/j.issn.1009-2137.2014.02.010. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014. PMID: 24762998 Chinese.
-
Clinical aspects of DIC--disseminated intravascular coagulation.Pol J Pharmacol. 1996 Jan-Feb;48(1):73-5. Pol J Pharmacol. 1996. PMID: 9112631
Cited by
-
Prediction model for mortality after intracranial hemorrhage in patients with leukemia.Am J Hematol. 2011 Jul;86(7):546-9. doi: 10.1002/ajh.22031. Epub 2011 Apr 20. Am J Hematol. 2011. PMID: 21509801 Free PMC article.
-
Pseudoplatelets: a retrospective study of their incidence and interference with platelet counting.J Clin Pathol. 2003 Oct;56(10):772-4. doi: 10.1136/jcp.56.10.772. J Clin Pathol. 2003. PMID: 14514782 Free PMC article.
-
Hemostatic changes in patients with malignancy.Int J Hematol. 2001 Feb;73(2):151-6. doi: 10.1007/BF02981931. Int J Hematol. 2001. PMID: 11372725 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials